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Abstract 
 
Disturbance of homeostasis within the ER lumen leads to the accumulation of 
unfolded and misfolded proteins. This results in the activation of an evolutionary conserved 
stress response termed ER stress that, if unresolved, induces apoptosis. We previously 
identified the Bcl-2 homology domain 3 (BH3)-Only Protein Puma as a mediator of ER 
stress-induced apoptosis in neurons. In the search of alternative contributors to ER stress-
induced apoptosis, we noted a downregulation of the anti-apoptotic Bcl-2 family protein Mcl-
1 during ER stress in both mouse cortical neurons and human SH-SY5Y neuroblastoma cells. 
Downregulation of Mcl-1 was associated with an upregulation of microRNA-29a (miR-29a) 
expression, and subsequent experiments showed that miR-29a targeted the 3’ UTR of the 
anti-apoptotic Bcl-2 family protein, Mcl-1. Inhibition of miR-29a expression using sequence 
specific antagomirs or the overexpression of Mcl-1 decreased cell death following 
tunicamycin treatment, while gene silencing of Mcl-1 increased cell death. miR-29a did not 
alter the signalling branches of the ER stress response, rather its expression was controlled by 
the ER stress-induced transcription factor activating-transcription-factor-4 (ATF4).  Our data 
demonstrate that the ATF4-mediated upregulation of miR-29a enhances the sensitivity of 
neurons to ER stress-induced apoptosis.  
Introduction 
 
Disturbance of homeostasis within the lumen of the endoplasmic reticulum (ER) often results 
in the accumulation of unfolded and misfolded proteins and activation of an evolutionary 
conserved stress response termed the unfolded protein response (Wang & Kaufman, 2012).  
The primary role of this response is to limit damage to the cells, however, under periods of 
extended or prolonged ER stress where irreparable damage has ensued, cell death via 
apoptosis is executed (Tabas & Ron, 2011). ER stress has been implicated in a number of 
pathophysiological conditions most notably those associated with disorders of the nervous 
system including amyotrophic lateral sclerosis (Kikuchi et al., 2006; Kieran et al., 2007; 
Saxena et al., 2009), Alzheimer’s disease (Kudo et al., 2002; Scheper et al., 2011) and 
Parkinson’s disease (Imai et al., 2000; Ryu et al., 2002). Therefore, further understandings of 
the role of ER stress in disease pathology are required and in particular the mechanisms 
involved in mediating cell death following prolonged ER stress. 
 
Central to the initiation of apoptotic signalling pathways are a family of proteins, termed the 
Bcl-2 protein family. These proteins have been linked to the regulation of the intrinsic 
pathway of apoptosis which is executed following the release of cytochrome c and other pro-
apoptotic factors from mitochondria (Llambi & Green, 2011). Members of the Bcl-2 family 
are classified on the basis of their function as either pro- or anti-apoptotic proteins. The pro-
apoptotic Bcl-2 family protein Bax and Bak are believed to constitute the release channel in 
the outer mitochondrial membrane through which pro-apoptotic factors are released, and are 
essential for the induction of apoptosis (Wei et al., 2001). Other pro-apoptotic members of 
the Bcl-2 family contain only a single Bcl-2 homology domain, the BH3-only proteins 
(Strasser, 2005). Under stress conditions these BH3-only proteins are activated either via 
transcription or via post-translational means. They serve to link the stress event to the 
initiation of apoptosis signalling cascade by activating Bax and Bak. By employing a 
transcriptome analysis of human SH-SY5Y neuroblastoma cells, we have previously 
investigated the genes involved in ER stress induced apoptosis in neural cells and identified 
the BH3-only protein, Puma, as an essential, stress-induced mediator of apoptosis within this 
paradigm (Reimertz et al., 2003; Concannon et al., 2008). ATF4, an ER stress-inducible 
transcription factor has been shown to activate puma gene expression in cortical neurons 
undergoing ER stress induced-apoptosis through upregulation of the transcription factor Chop 
(Galehdar et al., 2010). Of note, in neurons although loss of puma has a significant impact on 
ER stress mediated apoptosis residual levels of apoptosis are still evident (Reimertz et al., 
2003; Concannon et al., 2008; Galehdar et al., 2010). A previous study performed in non-
neuronal cells has also suggested a contribution of the BH3-only protein Bim during ER 
stress induced apoptosis (Puthalakath et al., 2007). Mouse embryonic fibroblasts deficient for  
the BH3-only protein Noxa have also been shown to be protected against ER stress-induced 
cell death (Li et al., 2006). Noxa induction during ER stress has been identified in parallel 
with Puma induction ( Pagliarini et al., 2015). Equally important for the sensitization of cells 
to ER stress-induced apoptosis may be a down-regulation of anti-apoptotic Bcl-2 family 
proteins, such as Bcl-2, Bcl-xL, Mcl-1, and Bcl-w. These function to inhibit the activity of 
Bax, Bak and BH3-only proteins. Indeed previous studies have demonstrated an important 
role for Bcl-2 and Bcl-xl in ER stress-induced apoptosis (Hacki et al., 2000; Kaufmann et al., 
2003).  
 
In recent years much research has eluded to the key role for micro RNAs, small non coding 
RNAs, as potent modulators of gene expression downstream of transcription (Bartel, 2009) . 
Micro RNAs (miRNAs) regulate the expression of proteins post-transcriptionally by their 
ability to bind to the 3’ untranslated region (UTR) of mRNAs resulting in either mRNA 
degradation or disruption of protein translation (Baek et al., 2008). We therefore sought to 
identify novel regulators of ER stress-induced apoptosis, and investigated the potential role of 
microRNA-29a (miR-29a) in mediating apoptosis. 
Materials and Methods 
 
Cell culture  
Human SH-SY5Y neuroblastoma cells were maintained in DMEM/F12 Ham (Sigma-Aldrich, 
Wicklow, Ireland) supplemented with 10% fetal bovine serum, 100 U/ml 
penicillin/streptomycin and 2 mM L-glutamine. The motor neuron-like NSC34 cells were 
maintained in DMEM high glucose (Lonza, Dublin, Ireland) supplemented with 10% fetal 
bovine serum, 100 U/ml penicillin/streptomycin and 2 mM L-glutamine. HeLa cells were 
maintained in RPMI1640 (Sigma-Aldrich) supplemented with 10% fetal bovine serum, 100 
U/ml penicillin/streptomycin and 2 mM L-glutamine. Cells were seeded at 3 x 105 cells per 6-
well plate and 1.5 x 105 cells per 24-well plate. After cells reached 70-80% confluence, 
experiments were initiated. 
 
Gene targeted mice  
puma-/- mice were generated as previously described (Bouillet et al., 1999; Villunger et al., 
2003). The puma-/- mice were generated on an inbred C57BL/6 background using C57BL/6-
derived embryonic stem (ES) cells. The bax-/- mice were obtained from Jackson Laboratory 
and maintained in house. The bax-/- mice were originally generated on a mixed 
C57BL/6_129SV genetic background, using 129SV-derived ES cells but had been 
backcrossed for >12 generations onto the C57BL/6 background. The genotype of bax-/- mice 
was confirmed by PCR as described by The Jackson Laboratory.  
 
Preparation of primary cortical neurons 
Mouse cortical neurons were isolated from C57BL/6J embryonic day 16 pups and prepared 
as described previously (Concannon et al, 2008). Briefly embryos (E15–16) were isolated 
from inbred C57BL6/J mouse by hysterectomy of the uterus following an abdominal 
injection of 0.2 ml of pentobarbital as lethal anaesthesia. The embryos were transferred to a 
dissection medium on ice (PBS with 0.25% glucose and 0.3% bovine serum albumin). The 
cerebral cortices from each of the embryos were isolated, the surrounding meninges removed 
and the tissue pooled in dissection media on ice. The tissue was incubated with trypsin (0.125 
mg/ml) at 37oC for 15 min. After the incubation, the trypsinization was stopped by addition 
of medium containing sera. The neurons were dissociated from tissue by gentle pipetting, 
centrifuged (200 x g for 3 min) and the medium was carefully aspirated. The neurons were 
resuspended in plating media (MEM containing 5% foetal calf serum, 5% horse serum, 100 
U/ml penicillin/streptomycin, 0.5 mM L-glutamine and 6% glucose) and plated at 7x105 
cells/ml on poly-lysine coated plates. Cells were incubated at 37oC, 5% CO2. The plating 
medium was exchanged with 50% feeding medium (Neurobasal medium (Invitrogen, Paisley, 
United Kingdom) - containing 100 U/ml of penicillin/streptomycin, 1% B27 supplement and 
0.5 mM L-glutamine) and 50% plating medium with additional 600 nM cytosine 
arabinofuranoside (Sigma) at DIV 2 and again exchanged to complete feeding medium at 
DIV 4. Experiments were performed from DIV 6 to DIV 9.  
 
Plasmids and transfection  
The shRNA vector targeting human Mcl-1 (pGFP-V-RS, TG 303313), the pCMV6-Mcl-1 
overexpression vector and the pCMV-pre-miRNA29a vector were purchased from Origene 
(Rockville, Maryland, USA) and the pcDNA3.1 control empty vector was purchased from 
Invitrogen (Paisley, United Kingdom). The shRNA vector targeting mouse Mcl-1 and the 
pLKO.1 control empty vector were obtained from Sigma-Aldrich. For inhibition of miR-29a 
expression a LNA oligonucleotide antagomir specific for miR-29a (Exiqon, Vedbaek, 
Denmark) or scrambled sequence (Exiqon) was used. In some experiments the pEGFP-N1 
plasmid (Clontech) was used to identify transfected cells as indicated. SH-SY5Y cells were 
transfected using Metafectene (Biontex, Martinsried, Germany) using the manufacturer’s 
protocol. NSC 34 cells and neocortical neurons were transfected using Lipofectamine 2000 
(Invitrogen, Paisley, United Kingdom) as per manufacturer’s instruction.  
 
Stem-loop reverse transcription and real-time qPCR using TaqMan low-density arrays 
Reverse transcription of 50 ng of RNA from Tunicamycin-treated SH-SY5Y cells at 4 h, 8 h 
and 24 h was carried out using the stem-loop Multiplex primer pools (Applied Biosystems), 
allowing reverse transcription of 48 different miRNA in each of eight RT pools. Reverse 
transcription for individual qPCRs was carried out using 50 ng of total RNA and the High-
Capacity Reverse Transcription Kit (Applied Biosystems). The microRNA qPCR screen was 
carried out on the 7900HT Fast Realtime System using TaqMan Low-Density Arrays 
(TLDA) (TaqMan TLDA MicroRNA Assays AIF v5 containing 364 human microRNAs 
assays; Applied Biosystems). RNU6 was used for normalization in microRNA expression 
studies. A relative fold change in expression of the target gene transcript was determined 
using the comparative cycle threshold method (2−ΔΔCT).  
 
Real time qPCR analysis of stem loop miRNAs 
Following treatment cells were harvested and the miRNA fraction extracted using the 
miRNeasy mini kit (Qiagen, Hilden, Germany). For miRNA cDNA synthesis, 100 ng of 
RNA was reverse transcribed using the Taqman miRNA reverse transcription kit (Applied 
Biosystems, Paisley, UK) in combination with miRNA specific primers for miR-29a or the 
control RNU19 (Applied Biosystems) as per manufacturer’s protocol. miRNA primer 
sequences were 5’-UAGCACCAUCUGAAAUCGGUU-3’ for miR-29a and  
5’-UUGCACCUCUGAGAGUGGAAUGACUC 
CUGUGGAGUUGAUCCUAGUCUGGGUGCAAACAAUU-3’ for RNU19 control. 
PCR amplification reactions were carried out in a total volume of 20 µl, containing 10 µl of 
TaqMan Master Mix (Applied Biosystems), 1.33 µl of cDNA and 1 µl of miRNA TaqMan 
probe and primers (Applied Biosystems). Cycling conditions were as follows: 95°C for 10 
min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. All PCR reactions were 
performed on the 7500 FAST RT-qPCR system (Applied Biosystems). Ct values were 
calculated using the SDS software v.2.1 using automatic baseline and threshold settings.  
 
RT-qPCR 
Total RNA was extracted using the Qiagen RNeasy minikit (Qiagen, Hilden, Germany). 
First-strand cDNA synthesis was performed using 1 µg of total RNA as the template and 
reverse transcribed using Superscript II (Invitrogen) primed with 50 pmol of random 
hexamers. Specific primers for each gene analysed were designed using Primer3 software. 
The sense and antisense primers were  
CAACACAAACCCCAAGCCT and CATTTGCAAACACCCTCCTT for bim, 
TCTCAGGAAAGGCTGCTGGT and GCTGGGCACTGGGTTAAGAA for puma, 
TCAGGAAGATCGGAGACAAA and TGAGCACACTCGTCCTTCAA for noxa, 
CTCATGGCCTTGTAGTTGAGA  and AGGGCATTTGAAGAACATGAC for xbp1, 
ACAGCAAGGAGGATGCCTTCT and GGCTGCTTATTAGTCTCCTGGAC for atf4 
AACCTCAGCCACTTTCTCCAG and GGCTCCGCTGAAGAGAGACTATT for atf6 and 
GGTGTGATGGTGGGAATGG and GGTTGGCCTTAGGGTTCAGG for β-actin. 
Quantitative real-time PCR (RT-qPCR) was performed using the LightCycler 4.0 (Roche 
Diagnostics, Basel, Switzerland) and the QuantiTech SYBR green PCR kit (Qiagen) as per 
manufacturer’s protocol. The PCRs were performed in 20 µl volumes with the following 
parameters – 95oC for 15 min, followed by 40 cycles of 94oC for 20 s, 58oC for 20 s and 72oC 
for 20 s. The generation of specific PCR products confirmed by melting curve analysis and 
gel electrophoresis. The data were analysed using the LightCycler software 4.0 and samples 
were normalised to β-actin.  
 
ER-stress reporter cell lines  
SH-SY5Y cell lines stably expressing YFP fluorescent labelled reporters indicating 
translation of ATF4 translation (PERK-reporter) or splicing of XBP1 (IRE1-reporter) were 
generated as described in (Walter et al., 2015). The ATF6-reporter construct was generated 
through amplifying the 5xATF6-binding site and adjacent c-fos promoter from the 5xATF6-
GL3 plasmid (Wang et al., 2000) using  primer    5’-
TAGATATTAATCTCGACCTGCAGCCC-3’ and 5’-
AATATTGAGCTCGGAGATCCTCTAGAG-3’ and cloning into pEYFP-N1 (Clontech) 
using AseI and SacI restriction sites, thus replacing the CMV-promoter. The 5xATF6-EYFP 
construct was transfected into SH-SY5Y cells and stable cells were selected in medium 
containing 0.5 mg/ml G418 (Sigma, Arklow, Ireland).  
 
High content live cell imaging  
High content live cell imaging and data processing was performed as described in (Walter et 
al., 2015). Briefly, ER-stress reporter cell lines were cultivated for 24 h in Nunc Micro Well 
96 well optical bottom 96 well plates. Prior to imaging the cells were stained with 100 ng/ml 
Hoechst 33588 and 2 μg/ml Propidium Iodide and treated with Tunicamycin, Thapsigargin or 
the same volume DMSO. The plate was incubated on stage at 37oC, 5% CO2 and imaged at 1 
h increments for 48 h using a Cellomics ArrayScan VTi instrument (Fisher Scientific) 
equipped with a × 10 PlanApo objective lens (NA 0.45), a 120 W Hg arc illumination source 
(EXFO, Chandlers Ford, UK) and a monochrome CCD camera 
(Orca Hamamatsu Photonics, Hertfordshire, UK). CellProfiler 2.0 cell image analysis 
software (Carpenter et al., 2006) was used to identify individual objects and measure their 
fluorescence intensity. Intensities of all images of the same channel were. A purpose built 
Matlab script (Matlab; MathWorks Inc., Cambridge, UK) was used to calculate and plot the 
fraction of dying cells and the mean of the mean YFP fluorescence intensity values of all 
cells per treatment group and time point as well as standard errors of these values.  
 
shRNA and lentivirus production/transduction   
MISSION shRNA vectors for gene silencing of ATF6 (clone number TRCN0000017855), 
XBP1 (TRCN0000019804) or ATF4 (TRCN0000013573) in mammalian cells and scrambled 
control containing plasmids were obtained from Sigma. Lentiviral particles were produced  
and transduction with lentiviral particles was conducted as described in (Walter et al., 2015).  
 
ER stress induction  
ER stress was induced by addition of 3 µM tunicamycin (Sigma-Aldrich) directly to the 
culture medium for the indicated time periods. DNA damage was induced by addition of  100 
µM etoposide (Sigma-Aldrich) directly to the culture medium for the indicated time periods. 
Control cells were treated with an equivalent volume of DMSO vehicle (Sigma-Aldrich). 
 
Annexin V/PI staining 
Cells were stained with Annexin V/Propidium iodide (BioVision, Mountain View, CA, USA) 
as per manufacturer’s instructions and analyzed using a CyFlow ML flow cytometer (Partec, 
Munster, Germany) and FloMax software. A minimum of 104 events were recorded for all 
samples and analyzed using FlowMax software (Partec). 
 
Determination of caspase-3-like protease activity  
DEVDase activity was determined fluorometrically using N-benzyloxycarbonyl-Asp-Glu-
Val-Asp-7-amino-4-methyl-coumarin (DEVD-AMC) as the substrate (10 µM). Cleavage of 
DEVD-AMC to liberate free AMC was monitored in live cells by measuring fluorescence 
after 1- and 2 h intervals. Protein content was determined using the Pierce Coomassie Plus 
protein assay reagent (Perbio, Northumberland, United Kingdom). Caspase activity was 
expressed as change in fluorescencent units per hour per microgram of protein. 
 
Quantification of cell death in neurons 
Neocortical neurons were stained with Hoechst 33342 (1 μg/ml) (Invitrogen) and propidium 
iodide (1 μg/ml) (Sigma-Aldrich) for 20 min in medium. Fluorescence was observed using a 
Nikon Eclipse TE 300 inverted microscope (Nikon, Düsseldorf, Germany) with a 20x 0.43 
NA phase-contrast objective using the appropriate filter for Hoechst and a charge-coupled 
device camera (SPOT RT SE 6; Diagnostics Instruments, Sterling Heights, MI). All 
experiments were performed at least three times from independent cultures. For each 
timepoint images of nuclei were captured in three subfields containing 300-400 neurons each 
and repeated in triplicate. Condensed and/or fragmented nuclei were scored as percent 
nuclear condensation and expressed as a percent of total population. Resultant images were 
processed using ImageJ (Micron-Optica; National Institute of Health) and AlphaEase 
software (Genetic Technologies, Miami, FL).  
 
Western blotting  
Preparation of cell lysates and western blotting was performed as described previously 
(Reimertz et al., 2003). The resulting blots were probed with a mouse monoclonal anti-Grp78 
antibody (BD Biosciences, New Jersey, USA) diluted 1:1000, a rabbit polyclonal anti-Chop 
antibody (Santa Cruz Biotechnology, CA, USA) diluted 1:250, a rabbit polyclonal anti-Mcl-1 
antibody (Rockland, Pennsylvania, USA) diluted 1:1,000 (specific for mouse Mcl-1, capable 
of detecting Mcl-1 on the outer mitochondrial membrane (OM) (40 kDa) and the inner 
mitochondrial membrane (IM) (36 kDa) of mitochondria (Perciavalle et al., 2012)),a mouse 
monoclonal anti-Mcl-1 antibody (BD Pharmingen, New Jersey, USA) diluted 1:1000 
(specific for human Mcl-1, detects Mcl-1 on the OM (40 kDa) of mitochondria),a rabbit 
polyclonal anti-Bim antibody (Stressgen, Victoria, Canada) diluted 1:1000, a mouse 
monoclonal anti-Xbp1antibody (BioLegend, San Diego, CA, USA) diluted 1:500, a rabbit 
polyclonal anti-Atf6 antibody (Santa Cruz Biotechnology, CA, USA) diluted 1:100,  a mouse 
monoclonal anti-tubulin antibody (Sigma-Aldrich, Tallaght, Dublin, Ireland) diluted 1:8,000, 
a mouse monoclonal anti-β-actin antibody (clone DM 1A; Sigma-Aldrich) diluted 1:8,000. 
Horseradish peroxidase–conjugated secondary antibodies diluted 1:5,000 (Thermo Fisher 
Scientific, Dublin, Ireland) were detected using Immobilin western chemiluminescent HRP 
substrate (Millipore, Cork, Ireland) and imaged using an imaging system (LAS-4000; 
Fujifilm, Sheffield, UK).  
 
Statistical Analysis  
For statistical comparison, when comparing two treatments, two-tailed Student’s t-test was 
used.  Data involving comparisons of more than two groups were analysed using one-way 
ANOVA followed by the Tukey’s post hoc analysis to determine differences amongst 
treatment groups. Values of p< 0.05 were considered to be statistically significant. All the 
data reported in the text and figures represent the mean±SEM. 
Results 
 
ER stress in cortical neurons is Bax-dependent but only partially PUMA-dependent - 
We assessed the ability of primary cortical neurons to undergo cell death following treatment 
with the inhibitor of N-glycosylation, tunicamycin. As demonstrated in Figure 1A, 
tunicamycin treatment of primary cortical neurons resulted in a time dependent increase in 
the number of neurons which displayed pyknotic nuclei and were propidium iodide (PI) 
positive (n=4 cultures per treatment, ANOVA post-hoc Tukey, pyknotic nuclei: F3,32=203.54, 
*p = 0.001 compared to control treated cultures, propidium iodide: F3,12=107.33, *p=0.001 
compared to control treated culture). This cell death was associated with increased DEVDase 
activity indicative of the activation of effector caspases-3 and-7 (n=4 cultures per treatment, 
ANOVA post-hoc Tukey, F3,16=6.15, *p=0.005 compared to control treated culture, Figure 
1C). Increased expression of known ER stress markers including the ER resident chaperone, 
Grp78, and the transcription factor Chop at both the mRNA and protein level were evident 
within this paradigm (n=3 cultures per treatment, ANOVA post-hoc Tukey, Grp78: 
F3,8=67.43, *p=0.001 compared to control treated culture, Chop:F3,8=9.02, *p=0.006 
compared to control treated culture, Figure 1D-G).  
 
We investigated the changes in the expression levels of several BH3-only proteins by qPCR 
during tunicamycin-induced ER stress. Tunicamycin treatment induced a prominent and time 
dependent up-regulation of puma mRNA (n=3 cultures per treatment, ANOVA post-hoc 
Tukey, F3,8=17.26, *p=0.0007 compared to control treated culture, Figure 2A). The 
expression of noxa mRNA was much more moderately affected (n=3 cultures per treatment, 
ANOVA post-hoc Tukey, F3,8=14.55, *p=0.0001 compared to control treated culture, Figure 
2B). Despite induction of bim mRNA (n=3 cultures per treatment, ANOVA post-hoc Tukey, 
F3,8=8.15, *p=0.0008 compared to control treated culture, Figure 2C), this was not reflected 
on a protein level with Bim protein expression unchanged or slightly decreased at 16 and 24 h 
(n=2 independent experiments, Figure 2D). In order to investigate the role of increased Puma 
expression in ER stress-induced apoptosis (Figure 2A), we utilized neurons from puma-/- 
mice and assessed the levels of cell death in response to tunicamycin treatment. Loss of Puma 
expression significantly protected cortical neurons from tunicamycin-induced cell death as 
assessed by reduced levels of nuclear apoptosis (n=4 cultures per treatment, ANOVA post-
hoc Tukey, F7,63=109.12, *p=0.001 compared to WT treated culture, Figure 2E). However, 
the protection seen in the absence of puma expression was not complete and suggested the 
involvement of other mechanisms in the activation of apoptosis in this setting. To assess 
whether cortical neuronal ER stress induced cell death was indeed dependent on the 
mitochondrial apoptosis pathway we treated bax -/- neurons with tunicamycin. As cortical 
neurons only express a non-functional form of Bak, N-Bak (Uo et al., 2005) loss of bax 
expression has been shown to be sufficient to prevent neuronal apoptosis induction by a 
variety of stimuli (Cregan et al., 1999). Loss of bax expression completely protected cortical 
neurons from cell death compared to wildtype (WT) neurons (n=3 independent samples, 
ANOVA post-hoc Tukey, F3,20=180, *p=0.003 compared to control treated culture, Figure 
2F) suggesting that bax-independent cell death did not play a significant role in this 
paradigm. 
 
Identification of miR-29a as an ER stress-induced miRNA - Previously, we have utilized 
high density microarrays to identify genes which are differentially regulated in SH-SY5Y 
neuroblastoma cells following treatment with the ER stressor, tunicamycin (Reimertz et al., 
2003). In order to investigate novel regulators of ER stress mediated apoptosis we chose to 
examine miRNA regulation in the same setting of SH-SY5Y cells which had the advantage of 
having been previously profiled for mRNA expression data as well as being a more  
homogenous cell composition compared to cortical neurons. To this end we treated SH-
SY5Y neuroblastoma cells with 3 µM  tunicamycin for 4, 8 and 12 h as described previously 
(Reimertz et al., 2003) after which we performed real time qPCR using Taqman low density 
arrays (TLDAs) to investigate changes in miRNA expression. Induction of ER stress within 
this setting was re-confirmed by the time dependent increase in the ER stress markers, Grp78 
and Chop on  mRNA level. The arrays were performed in duplicate with biological replicates 
for each time point. The cycle threshold value was calculated for each miRNA and 
normalised to RNU6 levels. The relative fold changes were calculated using the comparative 
cycle threshold method, and miRNAs defined as differentially expressed if their levels were 
changed by more than 1.5 fold on both arrays. Using these criteria, we identified hsa-miR-
29a to be 1.71 and 1.70 fold upregulated after 8 and 12 h of tunicamycin treatment.  
In order to validate the results of the TLDAs we performed real time qPCR analysis of miR-
29a expression in both SH-SY5Y neuroblastoma cells and primary cortical neurons. miR-29a 
demonstrated a time dependent increase in expression up to 24 h of tunicamycin treatment in 
the SH-SY5Y cells (n=3 independent samples, ANOVA post-hoc Tukey, F4=9.94, *p=0.0016 
compared to control treated culture, Figure 3A). In cortical neurons, miR-29a was 
significantly upregulated at 8 h, 16 h and 24 h tunicamycin treatment (n=3 independent 
samples, ANOVA post-hoc Tukey, F3=0.16, *p<0.05 compared to control treated culture, 
Figure 3B). Taken together, these data suggested that miR-29a was robustly increased during 
ER stress.  
 
Inhibition of miR-29a attenuates ER stress induced apoptosis - Previous work has 
identified members of the miR-29 family as proficient in targeting the 3’ UTR of the anti-
apoptotic Bcl-2 family protein Mcl-1 (Mott et al., 2007). We therefore next assessed whether 
modulation of miR-29a levels could affect cellular outcome following tunicamycin treatment. 
Initially we examined the constitutive overexpression of miR-29a by transfecting cells with a 
miR-29a expression plasmid driven by a CMV promoter and investigated the effects on 
tunicamycin-induced cell death. Increased expression of miR-29a resulted in increased levels 
of apoptosis under control conditions in SH-SY5Y cells. Furthermore, the increased 
expression of miR-29a resulted in enhanced sensitivity to ER stress induced apoptosis (n=3 
independent samples, ANOVA post-hoc Tukey, *p<0.05 compared to tunicamycin treated 
control antagomir transfected cultures, Figure 3C). In order to further investigate the 
functional significance of miR-29a upregulation during ER stress we investigated the effect 
of inhibiting miR-29a using sequence specific antagomirs. SH-SY5Y cells were transfected 
with either miR-29a antagomir or a control sequence and subsequently treated with 
tunicamycin to induce ER stress. Inhibition of miR-29a significantly decreased the levels of 
tunicamycin induced cell death (n=3 independent samples, ANOVA post-hoc Tukey, 
F3=15.45, *p=0.01  compared to tunicamycin treated control antagomir transfected cultures, 
Figure 3D). This result was paralleled in cortical neurons, where miR-29a inhibition provided 
significant protection against tunicamycin-induced apoptosis (n=3 cultures per treatment, 
ANOVA post-hoc Tukey, F3=12.73, *p=0.002 compared to control treated culture, Figure 
3E). Taken together these data suggest a role for miR-29a in mediating tunicamycin-induced, 
ER stress mediated apoptosis in neurons. 
 
Mcl-1 expression is decreased during ER stress and is sufficient to enhance 
susceptibility to ER stress - Using several miRNA target prediction algorithms (TargetScan, 
PicTar) we identified a previously characterized region within the 3’ UTR of Mcl-1 where 
miR-29a could potentially bind and was evolutionarily conserved across several species 
(Figure 4A). As demonstrated in Figure 4B and 4C, Western blot analysis demonstrated a 
time-dependent decrease in Mcl-1 expression in SH-SY5Y neuroblastoma cells and in 
primary cortical neurons during tunicamycin-induced ER stress using two distinct antibodies 
raised against Mcl-1 (n=3 independent experiments, Figure 4C. tunicamycin 2 h & 4 h n=2 
independent experiments).  
 
To investigate whether miR-29a targets the 3’UTR of Mcl-1 in neural cells, we generated 
luciferase expression plasmids whereby the 3’ UTR of Mcl-1 containing the putative miR-
29a binding site was cloned downstream of the luciferase coding sequence. Using this 
construct we could demonstrate decreased luciferase expression following tunicamycin 
treatment suggesting that the 3’ UTR of Mcl-1 was being targeted during ER stress (n=4 
independent samples, ANOVA post-hoc Tukey, F2=1.51, *p<0.05  compared to control 
treated cultures, Figure 4D). Furthermore, transfection with pre-miR-29a sequences 
significantly decreased luciferase expression compared to control pre-miR sequences again 
suggesting that miR-29a targeted the 3’ UTR of Mcl-1 (n=4 independent samples, ANOVA 
post-hoc Tukey, F1=33, *p=0.0012 compared to control pre-miR transfected cultures, Figure 
4E). In contrast, treatment with etoposide, a DNA damage inducing agent, failed to modulate 
luciferase expression levels suggesting that this was not an unspecific response to apoptosis 
induction (n=4 independent samples, Figure 4F).  
  
Modulation of Mcl-1 levels affects cellular sensitivity to ER stress induced cell death - 
To address whether the modulation of Mcl-1 levels may affect cellular outcome to ER stress 
induced cell death we first examined the effects of shRNA-mediated gene silencing of Mcl-1 
on apoptosis using a shRNA vector targeting human Mcl-1 (pGFP-V-RS, TG 303313)  
previously described by our group (Anilkumar et al., 2013). We confirmed shRNA-mediated 
knockdown of Mcl-1 in human HeLa cells (Figure 5A) and motoneuron-like NSC34 cells 
(Figure 5B). shRNA mediated silencing of Mcl-1 in SH-SY5Y cells greatly enhanced the 
number of cells undergoing apoptosis following tunicamycin treatment (n=4 independent 
samples, ANOVA post-hoc Tukey, *p<0.05 compared to control treated cultures, #p<0.05 
between indicated groups, Figure 5D). Next we quantified the effects of mcl-1 gene silencing 
in mouse neocortical neurons. Here we observed that shRNA silencing of Mcl-1 expression 
alone induced significant levels of apoptosis under control conditions and tunicamycin 
treatment suggesting the central role of Mcl-1 in regulating cell death in neurons (n=3 
independent samples, ANOVA post-hoc Tukey, F3=25.56, *p=0.0013 compared to control 
shRNA treated cultures, Figure 5C and 5E). To address whether overexpression of Mcl-1 
could protect from tunicamycin induced cell death we transfected cortical neurons from wild 
type mice with a Mcl-1 expression plasmid prior to tunicamycin treatment. As shown in 
Figure 5F, Mcl-1 overexpression significantly reduced the levels of tunicamycin-induced cell 
death in wildtype neurons, demonstrating that Mcl-1 played a key role in regulating ER stress 
induced cell death (n=3 independent samples, ANOVA post-hoc Tukey, F3=30.01, 
*p=0.0001 compared to control treated cultures, #p<0.05 between indicated groups, Figure 
5F).  
 
miR-29a inhibition does not alter ER stress responses  
To explore whether miR-29a also acted by modulating the ER stress response, we employed 
the previously described IRE1- and PERK-reporter cell lines (Walter et al., 2015). IRE1-
reporter cells stably expressed a full-length Xbp1-yfp construct. Upon ER stress activated 
IRE1 splices the 26 bp intron from Xbp1-yfp which leads to the translation of full length 
XBP1-YFP. The PERK-reporter construct contained three regulatory upstream ORF of 
human ATF4 in frame with YFP, which is sufficient for translation initiation following 
activation of PERK and phosphorylation of eIF2α under ER-stress conditions. Additionally 
we also generated an ATF6-reporter cell line, which stably expressed the ATF6-binding 
sequence, described by Wang et al, (Wang et al., 2000), which under ER-stress induced the 
transcription of yfp. To investigate whether miR-29a is involved in the regulation of ER-
stress responses PERK-, IRE1- or ATF6-reporter cells were transfected with antagomirs 
targeting human miR-29a or control. 48 h after transfection the cells were treated with 1 M 
tunicamycin, thapsigargin or control. The rate of fluorescent reporter activation in response to 
ER-stress over time was imaged for up to 48 h using high content live cell imaging (Figure 
6). Comparing the fluorescent intensities indicating ATF4-translation in response to 
tunicamycin or thapsigargin induced ER stress in the PERK-reporter cells transfected with 
antagomirs or control, we did not find any difference in the response between the two groups 
(n= 7 wells from two independent experiments, independent t-test, no significance between 
cells transfected with miR-29a antagomirs and cells transfected with control antagomirs, 
Figure 6A). Similarly, transfection with antagomirs did not appear to influence ER stress 
dependent splicing of XBP1 in the IRE1-reporter cells (n= 7 wells from two independent 
experiments, independent t-test, no significance between cells transfected with miR-29a 
antagomirs and cells transfected with control antagomirs, Figure 6B) nor ATF6 driven 
transcription of YFP in the ATF6-reporter cells (n= 7 wells from two independent 
experiments, independent t-test, no significance between cells transfected with miR-29a 
antagomirs and cells transfected with control antagomirs, Figure 6C). These experiments 
suggested that the cytoprotection afforded by miR-29a inhibition was not a result of altered 
ER stress response modulation.  
 
miR29a upregulation during ER stress 
Finally, we wished to explore which signalling arm of the ER stress response was responsible 
for the induction of miR-29a during ER stress.  To this end we employed lentiviral delivered 
shRNA constructs to effectively silence atf6, xbp1 and atf4 expression, respectively. The 
shRNA mediated loss of expression was confirmed by qPCR (n=3 independent samples, 
independent t-test, *p<0.05 compared control and knockdown groups, Atf6 DMSO: 
t4=4.56,*p=0.012, Atf6 Tuni: t4=30.77,*p=0.001, Xbp1 DMSO: t4=9.83,*p=0.001, Xbp1 
Tuni: t2=7.34,*p=0.002, Atf4 DMSO: t4=16.03,*p=0.0001, Atf4 Tuni: t4=10.66,*p=0.0004 , 
Figure 7A-C). We found expression levels of Atf6-, Xbp1- and Atf4 significantly reduced in 
response to 3 M tunicamycin as well as in control treated cells (n=3 independent samples, 
independent t-test, *p<0.05 compared control and knockdown groups, Atf4-kd DMSO: 
t4=8.70,*p=0.001, Atf4-kd Tuni: t4=4.64,*p=0.009, Figure 7D-E).  
Comparing miR-29a levels between cells deficient for Atf6, - Xbp1- or Atf4 expression and 
control cells we found no significant changes in the miR-29a levels in the cells silenced for 
Atf6 or Xbp1 compared cells transduced with scrambled control. However in cells transduced 
with shRNA targeting Atf4 we observed that miR-29a levels were lower than in control cells, 
suggesting a role for ATF4 or a downstream target of ATF4 in the regulation of miR-29a 
expression.  
Discussion 
 
In the present study we identified miR-29a to be robustly induced during ER stress in an 
ATF4-dependent manner. We also found miR-29a to target and inhibit expression of the anti-
apoptotic Bcl-2 protein, Mcl-1, and demonstrated a role for miR-29a in sensitizing cells to 
ER stress induced apoptosis.  
 
In our initial experiments we found ER stress induced apoptosis in cortical neurons to be 
dependent on bax expression. Activation of bax was likely to be mediated in part by 
induction of the BH3-only protein, Puma, with loss of puma expression protecting from cell 
death similar to what have been observed in other settings of ER stress induced death 
(Reimertz et al., 2003; Kieran et al., 2007; Concannon et al., 2008; Galehdar et al., 2010). In 
line with a previous report, we could not find a prominent role for bim in ER stress-induced 
apoptosis (Galehdar et al., 2010).  We did not observe Bim protein induction in the presence 
of mildly increased bim mRNA under conditions of tunicamycin treatment. Activation of 
PERK and phosphorylation of eIF2α following tunicamycin treatment could inhibit the cap-
dependent translation of Bim. At present, we cannot fully exclude the contribution of other 
pro-apoptotic BH3-only proteins to ER stress-induced neuronal apoptosis in our system 
(Wong et al., 2005, Concannon et al., 2010, Li et al., 2006). Nevertheless, we also sought to 
investigate other, “BH3-only protein-independent” mechanisms which could be controlling 
the activation of Bax. One such means could be the modulation of protein levels of anti-
apoptotic Bcl-2 family proteins by miRNA as demonstrated in previous studies (Mott et al., 
2007; Shimizu et al., 2010; Singh & Saini, 2012). Here, we identified an increased expression 
of miR-29a during ER stress, a miRNA that targets the expression of the anti-apoptotic Mcl-
1. Decreased expression of miR-29a has been associated with a number of malignancies 
including lung cancer (Fabbri et al., 2007) and anaplastic large cell lymphomas (Desjobert et 
al., 2011). Indeed, downregulation of miR-29a expression in anaplastic large cell lymphomas 
has been associated with blockage of apoptotic pathways with forced increased expression of 
miR-29a mediating increased levels of apoptosis and decreased expression of Mcl-1 
(Desjobert et al., 2011). Enforced expression of miR-29a has been associated with inducing 
apoptosis and growth arrest in hepatic cancer cells (Meng et al., 2010), while overexpression 
of miR-29a in pancreatic β cells decreased insulin production and increased apoptosis 
through targeting of Mcl-1 (Roggli et al., 2012).  We demonstrate that ER stress triggers 
miR-29a upregulation and cell death in SH-SY5Y cells and primary cortical neurons and 
subsequently targets Mcl-1 for translational repression and thereby decreases Mcl-1 protein 
levels.  We also provide direct evidence that miR-29a targets the 3’ UTR of Mcl-1 (Mott et 
al., 2007). Indeed, we could demonstrate that shRNA silencing of Mcl-1 enhanced cell death 
induced by ER stress. Furthermore, overexpression of Mcl-1 was sufficient to protect neurons 
from ER stress induced cell death. Interestingly, inhibition of Mcl-1 expression in SH-SY5Y 
cells did not significantly alter the basal levels of apoptosis, but had much more dramatic 
effects in cortical neurons. Previous studies have demonstrated the central role of Mcl-1 
expression in developing neurons with loss of Mcl-1 expression associated with increased 
levels of apoptosis and sensitivity to stressing agents such as DNA damage (Arbour et al., 
2008; Germain et al., 2011). Because Mcl-1 mediates an anti-apoptotic response in a variety 
of cell types and settings (Opferman et al., 2003; Opferman et al., 2005; Arbour et al., 2008), 
the identification of a miRNA that regulates Mcl-1 expression may suggest a possible 
therapeutic role for miR-29a modulation. Interestingly, downregulation of miR-29a 
expression has been demonstrated to be protective in a cardiac ischemia-reperfusion model 
(Ye et al., 2010) and has been shown to affect insulin secretion in mouse pancreatic β cells 
through selective gene targeting (Pullen et al., 2011), two settings where ER stress mediated 
cell death has been implicated (Toth et al., 2007; Lemaire & Schuit, 2012). In the latter 
paradigm, decreased expression of Mcl-1 has also been observed (Allagnat et al., 2011).  We 
also identified that the ER stress-induced activation of the transcription factor ATF-4 was 
required for miR-29a expression.  PERK activation and ATF4 signalling have been described 
as regulators of neurodegeneration and ER stress- induced apoptosis in disease models  of 
Alzheimer’s disease (Devi & Ohno, 2014),, Parkinson’s Disease (Wu et al., 2014) and ALS 
(Matus et al., 2013) suggesting that  inhibition of miR-29a could represent a novel 
therapeutic target for neurodegenerative disorders. ATF4 has previously been demonstrated 
to be an important ‘switch’ in ER stress-induced activation of apoptosis by upregulating the 
expression of puma (Galehdar et al., 2010). ATF4 therefore may mediate ER stress-induced 
apoptosis and  neurodegeneration by a dual action: activation of BH3-only protein expression 
and miR-induced downregulation of anti-apoptotic Mcl-1 expression.  
 
While our study and other studies demonstrated a pro-apoptotic role for miR-29a in neurons 
similar to previous studies in non-neuronal cells (Mott et al., 2007), evidence has also been 
presented that members of the miR-29 family, specifically miR-29b, may inhibit apoptosis 
through targeting of BH3-only proteins in other settings. miR-29b, a closely linked member 
of the miR-29 family has been shown to decrease expression of Bim and Puma and promote 
survival in mature sympathetic neurons following nutrient growth factor deprivation or 
etoposide treatment (Kole et al., 2011). miR-29a and miR-29b are co-expressed from the 
same chromosome/cluster and owing to their sequence similarity there is an expected   
redundancy in their target mRNAs. This suggests that the effects of the miR-29 family 
members must be highly context dependent. Effects may depend on the type of stress 
induced, or the type of cells in which the stress is induced. Therefore it is possible, in 
apoptosis paradigms where Mcl-1 is required for survival, miR-29a may mediate a pro-
apoptotic effect but in paradigms or cell types where there is less reliance on Mcl-1, miR-29a 
or miR-29b may mediate an anti-apoptotic effect. Clearly, miR-29a may also have important 
functions in neurons outside the control of cell death. miR-29a has been implicated in 
mediating synaptogenesis in psychoactive drug-treated hippocampal neurons through 
modulating dendritic spine morphology (Lippi et al., 2011). Furthermore, in Alzheimer’s 
disease, increased expression of BACE1 protein, a pathological event in the disease, was 
shown to correlate with decreased expression of miR-29a (Hebert et al., 2008). Interestingly, 
miR-29a/b-1 knockout mice presented with an ataxic phenotype and altered cerebellar 
morphology but unchanged levels of BACE-1 mRNA and protein, suggesting that targets 
other than BACE-1 mediated this phenotype (Papadopoulou et al., 2015).  miR-29a and 
downregulation of Mcl-1 may also serve as a signal for the induction of autophagy (Germain 
et al., 2011) to aid with the increased levels of misfolded and aggregated proteins seen during 
ER stress. As microRNAs have been shown to be quite promiscuous in their ability to target 
multiple sites and pathways in many cell types, Mcl-1 is clearly not the only major target of 
miR-29a. MiR-29a has been shown to have multiple targets across a range of non-neuronal 
systems (Fabbri et al., 2007). In Hela cells, miR-29a was shown to upregulate p53 levels and 
enhance apoptosis in a p53 dependent manner (Desjobert et al., 2011).  miR-29a has also 
been shown to target Voltage dependent anion channels, VDAC1 and VDAC2 (Bargaje et al., 
2012), which have been identified as playing a role in mediating ER stress induced apoptosis 
(Deniaud et al., 2008).  
 
In conclusion, our work shows a pro-apoptotic role for miR-29a involving Mcl-1 regulation 
in the setting of ER stress, and demonstrates that miR-29a expression during ER stress is 
controlled by the transcription factor ATF4.     
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 FIGURE LEGENDS 
 
FIGURE 1: ER stress induced apoptosis in primary cortical neurons is mediated in part by 
BH3-only protein Puma. (A) Significant increase in cell death in mouse cortical neurons 
treated with 3 µM tunicamycin observed in a time-dependent manner. Cell death was 
assessed by Hoechst and propidium iodide staining. (B) Representative images of primary 
cortical neurons treated with 3 µM tunicamycin or control (0.1% DMSO) for 24 h. Cells were 
stained with Hoechst 33358 or propidium iodide.(C) Significant changes in caspase-3 like 
(DEVDase) activity were observed at 16 h and 24 h in cortical neurons treated as described 
above and expressed relative to non-treated controls (D) Treatment of mouse cortical neurons 
with 3 µM tunicamycin significantly alters grp78 mRNA expression across time. grp78 
mRNA expression were normalised to β-actin and expressed relative to control treated 
cultures. (E) Treatment of mouse cortical neurons with 3 µM tunicamycin significantly alters 
chop mRNA expression across time. chop mRNA expression were normalised to β-actin and 
expressed relative to control treated cultures. (F-G) Cortical neurons were treated with 3 µM 
tunicamycin or control (0.1% DMSO) for the indicated time periods. Increased expression of 
Grp78 and Chop were analyzed by Western blotting. Probing for β-actin served as the 
loading control. Scale bar:=20 µM. Error bars indicate SEM. *indicates statistical significant 
increase (p<0.05) 
 
FIGURE 2: Regulation of BH3-only proteins in altered during ER stress in cortical neurons. 
(A-C) Significant time-dependent increases in puma, noxa and bim mRNA were observed in 
cortical neurons from wildtype (WT) mice treated with 3 µM tunicamycin or control ( 0.1% 
DMSO) for indicated time points. Expression levels were normalised to β-actin and 
expressed relative to control treated cultures.(D) Densitometry analysis showing Bim levels 
in cortical neurons treated with 3 µM tunicamycin or control (0.1% DMSO) for the indicated 
time periods (upper panel). Western blot analysis of cortical neurons treated with 3 µM 
tunicamycin or control (0.1% DMSO) for the indicated time periods.. Probing for β-actin 
served as the loading control (lower panel). (E) Significant decrease in nuclear apoptosis was 
observed in cortical neurons from wild type (WT) and puma-/- mice were treated with 3 µM 
tunicamycin. Cell death assessed using Hoechst staining. (F) Significant decrease in nuclear 
apoptosis was observed in cortical neurons from wild type (WT) and bax-/- mice were treated 
with 3 µM tunicamycin for 24 h. Cell death was assessed by Hoechst staining and counting of 
apoptotic nuclei. Error bars indicate SEM. *indicates statistical significant increase (p<0.05) 
 
FIGURE 3: Modulation of miR-29a expression during ER stress is associated with altered 
levels of cell death. (A) SH-SY5Y neuroblastoma cells were treated with 3 µM tunicamycin 
for varying time periods (4-24 h) or control (0.1% DMSO). Significant changes in expression 
levels of miR-29a were examined using real time qPCR. (B) Primary cortical neurons were 
treated with 3 µM tunicamycin for varying time periods (8-24 h) or control (0.1% DMSO). 
Significant changes in expression levels of miR-29a were examined using real time qPCR.   
(C) Increased miR-29a expression increases % nuclear apoptosis in SH-SY5Y cells treated 
with 3 µM tunicamycin or DMSO (control) for 30 h. Cell death was assessed by Hoechst 
staining and counting of apoptotic nuclei. (D) Reduced expression of miR-29a using 30 nM 
miR-29a antagomir decreased cell death in SH-SY5Y cells compared to control antagomir. 
Cell death was assessed by annexin V and propidium iodide staining and subsequent flow 
cytometry analysis. (E) Significant decrease in nuclear apoptosis was achieved in primary 
cortical neurons transfected with 50 nM of control or miR-29a specific antagomir and treated 
with 3 µM tunicamycin for 24 h. Nuclei were stained with Hoechst33358 and morphology of 
pyknotic nuclei was assessed using Image J software (National Institute of Health). Error bars 
indicate SEM. *indicates statistical significant increase (p<0.05), (#p<0.05) between 
indicated groups. 
 
FIGURE 4: miR-29a targeting of Mcl-1 3’UTR reduces Mcl-1 expression during ER stress 
(A) Schematic shows 3’ UTR of Mcl-1 where miR-29a can bind is shown in red box (B) 
Densitometry analysis showing  time course of Mcl-1 expression in SH-SY5Y cells treated 
with 3 µM tunicamycin or control (0.1% DMSO) for indicated time periods (upper panel).  
Western blot analysis of Mcl-1 expression in SHSY5Y cells treated with 3 µM tunicamycin 
or control (0.1% DMSO) for indicated time periods (lower panel). Anti-Mcl-1 antibody 
specific for human Mcl-1 was used (BD Pharmingen). Probing with β-actin served as a 
loading control. (C) Densitometry analysis showing Mcl-1 levels in cortical neurons treated 
with 3 µM tunicamycin or control (0.1% DMSO) for indicated time periods (upper panel). 
Western blot analysis of Mcl-1 expression in primary cortical neurons treated with 3 µM 
tunicamycin or control (0.1% DMSO) for indicated time periods. Anti-Mcl-1 antibody 
specific for mouse Mcl-1 was used (Rockland). Probing with β-actin served as a loading 
control (lower panel). (D) Tunicamycin treatment significantly alters expression of Mcl-1 3’ 
UTR. SH-SY5Y cells were transfected with a plasmid containing the 3’ UTR of Mcl-1. After 
24 h the cells were treated with 3 µM tunicamycin for 24 h or control (0.1% DMSO). (E) 
Increased miR-29a expression significantly alters Mcl-1 3’ UTR expression. Cells were 
transfected with a plasmid containing the 3’ UTR of Mcl-1 and either pre-miR-29a sequence 
or a control pre-miR sequence. (F) Etoposide treatment did not significantly alter Mcl-1 3’ 
UTR expression. SH-SY5Y cells were transfected with a plasmid containing the 3’ UTR of 
Mcl-1. After 24 h the cells were treated with 100 µM etoposide for 24 h or control (0.1% 
DMSO). All luciferase assays were performed and normalized for the co-transfected Renilla 
expression. Error bars indicate SEM. *indicates statistical significant increase (p<0.05) 
 
FIGURE 5: Modulation of Mcl-1 levels affects cellular sensitivity to ER stress induced cell 
death. (A-B) Representative Western blots of Mcl-1 levels after transfection with indicated 
shRNA plasmid and probing with Mcl-1 human or mouse specific antibodies in HeLa cells 
(A). or NSC34 cells (B). Probing with β-actin served as a loading control . (C) Representative 
images of primary cortical neurons transfected with Mcl-1 shRNA or control shRNA and 
treated with 3 µM tunicamycin or control (0.1% DMSO) for 24 h. Cells were stained with 
Hoechst 33358 and imaged using Image J software (National Institute of Health). (D) 
Tunicamycin-induced cell death was significantly increased with shRNA knockdown of Mcl-
1 expression. SH-SY5Y cells were transfected with a shRNA targeting Mcl-1. After 24 h 
transfection cells were treated with 3 µM tunicamycin or control (0.1% DMSO) for a further 
24 h. Cell death was assessed by means of PI staining/ GFP expression and subsequent flow 
cytometry analysis. (E) Significant changes in % nuclear apoptosis were seen with decreased 
Mcl-1 expression irrespective ER stress. Mouse neocortical neurons were transfected with a 
shRNA targeting Mcl-1. After 24 h transfection cells were treated with 3 µM tunicamycin or 
control (0.1% DMSO) for a further 24 h. Cell death was assessed by Hoechst staining and 
counting of apoptotic nuclei. (F) Overexpression of Mcl-1 significantly decreased 
tunicamycin induced cell death. Mouse neocortical neurons from wildtype (WT) mice were 
transfected with an Mcl-1 overexpression vector. After 24 h transfection cells were treated 
with 3 µM tunicamycin or control (0.1% DMSO) for a further 24 h. % nuclear apoptosis was 
assessed by Hoechst staining and counting of apoptotic nuclei. Scale bar = 10 µm. Error bars 
indicate SEM. *indicates statistical significant increase (p<0.05), (#p<0.05) between 
indicated groups. 
FIGURE 6: MiR-29a inhibition does not alter ER-stress responses. SH-SY5Y cells stably 
expressing fluorescent protein reporter constructs for the activation of (A) PERK (B) 
activation and splicing activity of IRE1 or (C) cleavage and transcriptional activity of ATF6 
were transfected with antagomirs targeting miR-29a or control. 48 h after transfection the 
cells were treated with 1 M Tuni or 0.1 % DMSO stained with Hoechst and PI. (A, C) Mean 
fluorescence intensity per cell or (B) amount of YFP positive cells over time were monitored 
over time employing live-cell high content imaging (left panel). Images were taken at 1 h 
intervals starting immediately after treatment for up to 48 h. Error bars indicate S.E.M. of all 
cells per time point and treatment. The experiments were repeated with similar results. Right 
panel: YFP mean fluorescence intensity after 30 h (A,C) or 16 h (B) after treatment.  
 
FIGURE 7: miR-29a regulation during ER-stress. SH-SY5Y cells were transduced with 
shRNA targeting atf6, xbp1, atf4 or scrambled control. 72 h after transduction cells were 
treated for 24 h with 3 M Tuni or 0.1 % DMSO (A-C) Expression levels of atf6-, xbp1- and 
atf4 were analysed using qPCR. Expression levels were normalised to β-actin and expressed 
relative to DMSO or Tuni treated scrambled control.  miR-29a expression levels in untreated 
(D) or Tuni (E) treated cell atf6-, xbp1- and atf4-silenced cells were assessed using qPCR. 
Expression levels were normalised to RNU19 control and expressed as n-fold over DMSO or 
Tuni treated scrambled control. Error bars indicate SEM. *indicates statistical significant 
increase (p<0.05),  
 
 
 
 
 
